Skip to main content
. 2023 Jul 20;8(3):233–247. doi: 10.1038/s41551-023-01067-5

Extended Data Fig. 5. Severity-specific changes in glycopeptide feature abundance in COVID-19 patient plasma.

Extended Data Fig. 5

Abundances of glycopeptides identified in the COVID-19 cohort, grouped by disease severity. Values are log2-transformed, box-and-whisker plot displays 25th, 50th (median) and 75th percentile in the box. Whiskers display upper/lower limits of data. Plot labels show gene, glycosylation site and glycan composition.